Surrozen, Inc./DE - SRZN

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$313.6M

QoQ value delta ($000)

+$118.6M (+60.79%)

Implied price effect (QoQ)

+33.4%

Total shares

10,839,744

QoQ shares delta

+1,846,688 (+20.53%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 59 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Column Group LLC	55,840	1,916,950	55.45%
TCG Crossover Management, LLC	42,911	1,473,101	1.23%
Boxer Capital Management, LLC	22,322	766,318	2.93%
MILLENNIUM MANAGEMENT LLC	21,298	731,138	0.01%
Venrock Adviser, LLC	18,437	632,931	0.69%
Spruce Street Capital LP	12,585	432,040	3.03%
BRAIDWELL LP	11,538	396,100	0.38%
5AM Venture Management, LLC	11,287	387,500	3.13%
Kalehua Capital Management LLC	11,220	385,178	9.46%
Vestal Point Capital, LP	9,863	338,611	0.28%
Vivo Capital, LLC	7,573	260,000	0.63%
VANGUARD GROUP INC	7,214	319,236	0.0%
PERCEPTIVE ADVISORS LLC	6,682	229,393	0.13%
Woodline Partners LP	6,637	227,848	0.03%
BALYASNY ASSET MANAGEMENT L.P.	5,939	203,888	0.01%
STEMPOINT CAPITAL LP	5,708	195,981	1.11%
Ikarian Capital, LLC	5,042	173,107	0.41%
ACUTA CAPITAL PARTNERS, LLC	5,035	172,847	3.55%
VANGUARD CAPITAL MANAGEMENT LLC	4,925	169,092	0.0%
AMERIPRISE FINANCIAL INC	4,652	159,711	0.0%
SILVERARC CAPITAL MANAGEMENT, LLC	4,202	144,255	0.43%
REGENTS OF THE UNIVERSITY OF CALIFORNIA	3,880	133,207	0.14%
ADAGE CAPITAL PARTNERS GP, L.L.C.	2,582	88,653	0.0%
Euclidean Capital LLC	2,554	87,696	0.65%
FRED ALGER MANAGEMENT, LLC	2,088	71,697	0.01%